Search results
33 Unwritten Rules Of Being Poor That You Only Could Know About If You've Struggled Financially
BuzzFeed via Yahoo News· 2 days agoWe knew the exact date of grocery shopping because that's when the food stamps came in." 16."We...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoHemgenix gained U.S. approval in late 2022 and also costs $3.5 million before insurance deductions...
47 Ohio cities so far have banned recreational marijuana dispensaries: The Wake Up for Wednesday,...
The Cleveland Plain Dealer· 2 days agoBy mid-June, recreational marijuana dispensaries could be open to Ohioans 21 and older — but not in...
Poll: 1 in 8 U.S. adults have tried weight-loss drugs like Wegovy, Ozempic - UPI.com
UPI· 7 days agoMost patients say they use the drugs (61%) to treat a chronic condition like diabetes or heart...
Council Post: Two Unconventional Wisdoms From The Playbook Of Innovative Entrepreneurs
Forbes· 1 day agoMelanie, CEO of Defining Moments Publishing, is a top leadership expert, speaker and author who's...
New Technology Puts Financial Improvements on the Menu for Restaurants
PYMNTS.com· 4 days agoA report from Fiserv went into more detail. The Fiserv Small Business Index showed that small...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoTendon Allograft Market to Reach $42.7 Billion Globally by 2032 at 5.2% CAGR: Allied Market Research PR Newswire PORTLAND, Ore., May 13, 2024 The increasing focus on sports ...
New events, new beverage lines: Wineries adapt to survive in 2024 - Buffalo Business First
The Business Journals· 7 days agoWith age comes wisdom, and that’s certainly true among wineries on the Niagara Wine Trail, where...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days ago— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED’s surufatinib and anti-PD-1 activity with Hengrui’s